Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.2
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2021   100,192,562    
Beginning balance at Dec. 31, 2021 $ 300,624,207 $ 100,193 $ 553,472,292 $ (252,948,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation 1,521,910   1,521,910  
Net income 7,112,043     7,112,043
Ending balance (in shares) at Mar. 31, 2022   100,192,562    
Ending balance at Mar. 31, 2022 309,258,160 $ 100,193 554,994,202 (245,836,235)
Beginning balance (in shares) at Dec. 31, 2021   100,192,562    
Beginning balance at Dec. 31, 2021 300,624,207 $ 100,193 553,472,292 (252,948,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 49,056,465      
Ending balance (in shares) at Jun. 30, 2022   107,236,111    
Ending balance at Jun. 30, 2022 358,007,259 $ 107,236 561,791,836 (203,891,813)
Beginning balance (in shares) at Mar. 31, 2022   100,192,562    
Beginning balance at Mar. 31, 2022 309,258,160 $ 100,193 554,994,202 (245,836,235)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Induced exercise of common warrants issued in offering (in shares)   6,453,907    
Induced exercise of common warrants issued in offering 5,163,126 $ 6,454 5,156,672  
Options exercised (in shares)   100,000    
Options exercised 0 $ 100 (100)  
Shares elected to be withheld for options exercised (in shares)   (47,506)    
Shares elected to be withheld for options exercised 0 $ (48) 48  
Restricted stock vested (in shares)   610,195    
Restricted stock vested 0 $ 610 (610)  
Shares to cover tax withholding for restricted stock vested (in shares)   (73,047)    
Shares to cover tax withholdings for restricted stock vested 0 $ (73) 73  
Payments to cover tax withholdings for restricted stock vested, net (257,694)   (257,694)  
Share-based compensation 1,899,245   1,899,245  
Net income 41,944,422     41,944,422
Ending balance (in shares) at Jun. 30, 2022   107,236,111    
Ending balance at Jun. 30, 2022 358,007,259 $ 107,236 561,791,836 (203,891,813)
Beginning balance (in shares) at Dec. 31, 2022   175,530,212    
Beginning balance at Dec. 31, 2022 661,103,391 $ 175,530 775,241,114 (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Induced exercise of common warrants issued in offering (in shares)   4,517,427    
Induced exercise of common warrants issued in offering 3,613,941 $ 4,517 3,609,424  
Restricted stock vested (in shares)   659,479    
Restricted stock vested 0 $ 659 (659)  
Shares to cover tax withholding for restricted stock vested (in shares)   (79,634)    
Shares to cover tax withholdings for restricted stock vested 0 $ (79) 79  
Payments to cover tax withholdings for restricted stock vested, net (134,381)   (134,381)  
Share-based compensation 1,943,696   1,943,696  
Net income 32,715,779     32,715,779
Ending balance (in shares) at Mar. 31, 2023   180,627,484    
Ending balance at Mar. 31, 2023 699,242,426 $ 180,627 780,659,273 (81,597,474)
Beginning balance (in shares) at Dec. 31, 2022   175,530,212    
Beginning balance at Dec. 31, 2022 661,103,391 $ 175,530 775,241,114 (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 61,507,384      
Ending balance (in shares) at Jun. 30, 2023   195,350,672    
Ending balance at Jun. 30, 2023 738,840,316 $ 195,350 791,450,835 (52,805,869)
Beginning balance (in shares) at Mar. 31, 2023   180,627,484    
Beginning balance at Mar. 31, 2023 699,242,426 $ 180,627 780,659,273 (81,597,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Induced exercise of common warrants issued in offering (in shares)   14,512,166    
Induced exercise of common warrants issued in offering 8,687,655 $ 14,512 8,673,143  
Restricted stock vested (in shares)   288,709    
Restricted stock vested 0 $ 289 (289)  
Shares to cover tax withholding for restricted stock vested (in shares)   (77,687)    
Shares to cover tax withholdings for restricted stock vested 0 $ (78) 78  
Payments to cover tax withholdings for restricted stock vested, net (141,682)   (141,682)  
Share-based compensation 2,260,312   2,260,312  
Net income 28,791,605     28,791,605
Ending balance (in shares) at Jun. 30, 2023   195,350,672    
Ending balance at Jun. 30, 2023 $ 738,840,316 $ 195,350 $ 791,450,835 $ (52,805,869)